{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:43:34Z","timestamp":1782218614257,"version":"3.54.5"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Both parapsoriasis and LyP appear clinically as inflammatory dermatoses with a paradoxical link to cMF. A key element in addressing the relationship of parapsoriasis and MF were the results of the French and Dutch long-term registries tracking the emergence of lymphomas in the setting of LyP. Both cMF and cALCL emerged almost equally in these long-term studies. This ultimately supports that the stem cells in both cMF and cALCL are probably derived from a common stem cell shared by CD4+\/CD8+ memory stem cells defining cMF and CD30+ stem cells defining cALCL. The discovery of inducible Skin Associated Lymphoid Tissue (iSALT) mesenchymal hubs incorporating Tregs, with their pleiotropic functions represents a paradigm shift and formed a translational tool in this analysis of the paradox. LyP can be recast as activated inhibitory lymphomatoid T-cell hubs derived from inducible iTregs in iSALT and the source of the common stem cell LyP line. iSALT Treg integrated mesenchymal hubs provided an emerging translational tool in redefining integrated lymphomatoid pathways. Brocq\u2019s complex scheme defining parapsoriasis as hybrid inflammatory dermatoses with a paradoxical link to cMF became a template to preserve parapsoriasis as a clinical diagnosis. Two major iSALT Treg generated inhibitory integrated lymphomatoid hubs emerged. The major CD30+TNF lymphomatoid hub has been linked to cALCL. Clinically defined chronic regressing and relapsing parapsoriasis with the histopathology of patch stage MF can be redefined as lymphomatoid parapsoriasis. This twin inhibited oncogenic memory based hub is defined by Treg modulated, CD4+\/CD8+memory linked PD-1\/DL-1 cytoxic complex and lichenoid histopathology.<\/jats:p>","DOI":"10.1097\/dad.0000000000002546","type":"journal-article","created":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T12:00:10Z","timestamp":1696248010000},"page":"753-761","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Critical Review\u2014A Tribute to Louis Brocq Lymphomatoid Papulosis, the Key in Exploring the Relationship of Parapsoriasis and Mycosis Fungoides"],"prefix":"10.1097","volume":"45","author":[{"given":"Steven","family":"Kossard","sequence":"first","affiliation":[{"name":"Kossard Dermatopathologists, Laverty Pathology, Macquarie Park, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,9,27]]},"reference":[{"key":"R1-20250616","first-page":"315","article-title":"Les parapsoriasis","volume":"35","author":"Brocq","year":"1902","journal-title":"Ann Dermatol Syphilgr (Paris)"},{"key":"R4-20250616","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/cup.13990","article-title":"Shall we exclude parapsoriasis from medical vocabulary?","volume":"48","author":"Xavier","year":"2021","journal-title":"J Cutan Pathol."},{"key":"R6-20250616","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00000372-197901010-00002","article-title":"The patch stage mycosis fungoides: criteria for histologic diagnosis","volume":"1","author":"Sanchez","year":"1979","journal-title":"Am J Dermatopathol."},{"key":"R7-20250616","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/archderm.1968.01610070029004","article-title":"Lymphomatoid papulosis: a continuing self-healing eruption, clinically benign-histologically malignant","volume":"97","author":"Macaulay","year":"1968","journal-title":"Arch Dermatol."},{"key":"R8-20250616","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1634\/theoncologist.2015-0242","article-title":"Frequency and risk factors for associated lymphomas in patients with lymphomatoid papulosis","volume":"21","author":"Cordel","year":"2016","journal-title":"Oncologist"},{"key":"R9-20250616","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/jdv.16065","article-title":"Frequency and prognosis of associated malignancies in 504 patients with lymphomatoid papulosis","volume":"34","author":"Melchers","year":"2020","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"suppl l","key":"R10-20250616","first-page":"12s","article-title":"Skin-associated lymphoid tissue (SALT): origins and functions","volume":"80","author":"Streilin","year":"1983","journal-title":"J Invest Dermatol."},{"key":"R11-20250616","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s40629-015-0065-1","article-title":"Novel insights into the role of immune cells in skin and inducible skin-associated lymphoid tissue (iSALT)","volume":"24","author":"Ono","year":"2015","journal-title":"Allergo J Int."},{"key":"R13-20250616","first-page":"372","article-title":"Regulatory T cells in skin","volume":"152","author":"Ali","year":"2017","journal-title":"Regul T Cell Skin Immunol."},{"key":"R14-20250616","first-page":"42","article-title":"The clinical and histopathologic spectrum of lymphomatoid papulosis","volume":"45","author":"Willemze","year":"1982","journal-title":"Br J Dermatol."},{"key":"R15-20250616","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/299065a0","article-title":"Production of a monoclonal antibody specific for Hodgkin and Sternberg\u2013Reed cells of Hodgkin\u2019s disease and a subset of normal lymphoid cells","volume":"299","author":"Schwab","year":"1982","journal-title":"Nature"},{"key":"R16-20250616","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.V66.4.848.848","article-title":"The expression of the Hodgkin\u2019s disease associated antigen Ki1in reactive and neoplastic lymphoid tissue: evidence that Reed\u2013Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells","volume":"66","author":"Stein","year":"1985","journal-title":"Blood"},{"key":"R18-20250616","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1097\/PAS.0b013e3181bf677d","article-title":"CD30 expression and proliferative fraction in nontransformed mycosis fungoides","volume":"33","author":"Edinger","year":"2009","journal-title":"Am J Surg Pathol."},{"key":"R19-20250616","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/bjd.13690","article-title":"Assessment of diagnostic criteria between primary cutaneous anaplastic large-cell lymphoma and CD30-rich transformed mycosis fungoides: a study of 66 cases","volume":"172","author":"Fauconneau","year":"2015","journal-title":"Br J Dermatol."},{"key":"R20-20250616","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0002-9440(10)65018-3","article-title":"Regulation of CD30 antigen expression and its potential significance for human disease","volume":"156","author":"Kadin","year":"2000","journal-title":"Am J Pathol."},{"key":"R21-20250616","doi-asserted-by":"crossref","first-page":"733484","DOI":"10.3389\/fimmu.2021.733484","article-title":"Putative immunological functions of inducible skin-associated lymphoid tissue in the context of mucosa associated lymphoid tissue","volume":"12","author":"Kogame","year":"2021","journal-title":"Front Immunol."},{"key":"R22-20250616","first-page":"187","article-title":"Do epidermal cells produce thymic hormones in vivo? An immunohistochemical study using anti-thymic hormone antibodies","volume":"12","author":"Nicolas","year":"1988","journal-title":"Thymus"},{"key":"R23-20250616","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1369\/00221554211025489","article-title":"Telocytes: an emerging component of stem cell niche microenvironment","volume":"69","author":"Rosa","year":"2021","journal-title":"J Histochem Cytochem."},{"key":"R24-20250616","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41536-019-0083-6","article-title":"Mesenchymal stem cell perspective: cell biology to clinical progress","volume":"4","author":"Pittenger","year":"2019","journal-title":"NPJ Regen Med."},{"key":"R25-20250616","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1182\/blood-2006-07-038455","article-title":"Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease","volume":"109","author":"Zeiser","year":"2007","journal-title":"Blood"},{"key":"R26-20250616","first-page":"608951","article-title":"Regulatory T cells in allogeneic stem cell transplantation","volume":"207","author":"Michael","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"R27-20250616","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cmet.2019.09.010","article-title":"Roles of regulatory T cells in tissue pathophysiology and metabolism","volume":"31","author":"Campbell","year":"2020","journal-title":"Cell Metab."},{"key":"R28-20250616","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"R29-20250616","doi-asserted-by":"crossref","first-page":"269rv1","DOI":"10.1126\/scitranslmed.3010641","article-title":"Resident memory T cells in human health and disease","volume":"7","author":"Clark","year":"2015","journal-title":"Sci Transl Med."},{"key":"R30-20250616","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.immuni.2018.01.007","article-title":"Human T cell development, localization and function throughout life","volume":"48","author":"Kumar","year":"2018","journal-title":"Immunity"},{"key":"R33-20250616","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-0536.1976.tb03012.x","article-title":"Lymphomatoid contact dermatitis A syndrome produced by epicutaneous hypersensitivity with clinical features and a histopathologic picture similar to that of mycosis fungoides","volume":"2","author":"Gomez-Orbaneja","year":"1976","journal-title":"Contact Dermatitis"},{"key":"R34-20250616","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0190-9622(81)70100-2","article-title":"The nosology of parapsoriasis","volume":"5","author":"Lambert","year":"1981","journal-title":"J Am Acad Dermatol."},{"key":"R35-20250616","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF02002046","article-title":"Ube die pityriasis lichenoides chronica (psoriasiform exanthema)","volume":"50","author":"Juliusberg","year":"1899","journal-title":"Archiv f\u00fcr Dermatologie und Syphilis"},{"key":"R36-20250616","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archderm.1990.01670350063008","article-title":"Cutaneous T-cell lymphoma (parapsoriasis en plaque): an association with pityriasis lichenoides et varioliformis acuta in young children","volume":"126","author":"Fortson","year":"1990","journal-title":"Arch Dermatol."},{"key":"R37-20250616","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2133.2000.03307.x","article-title":"Pityriasis lichenoides-like mycosis fungoides in children","volume":"142","author":"Ko","year":"2000","journal-title":"Br J Dermatol."},{"key":"R39-20250616","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0190-9622(85)70183-1","article-title":"Clinical and histologic differentiation between lymphomatoid papulosis and pityriasis lichenoides","volume":"13","author":"Willemze","year":"1985","journal-title":"J Am Acad Dermatol."},{"key":"R40-20250616","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0190-9622(87)70074-7","article-title":"Immunohistology of pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides chronica","volume":"16","author":"Wood","year":"1987","journal-title":"J Am Acad Dermatol."},{"key":"R42-20250616","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/pde.12019","article-title":"Pediatric follicular mucinosis: presentation, histopathology, molecular genetics, treatment, and outcomes over an 11-year period at the Mayo clinic","volume":"30","author":"Alikhan","year":"2013","journal-title":"Pediatr Dermatol."},{"key":"R43-20250616","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jaad.2012.04.015","article-title":"Clinical and histopathologic spectrum of alopecia mucinosa\/follicular mucinosis and its natural history in children","volume":"67","author":"Zvulunov","year":"2012","journal-title":"J Am Acad Dermatol."},{"key":"R44-20250616","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.1440-0960.2000.00409.x","article-title":"Folliculotropic T-cell lymphocytosis (mucin-poor follicular mucinosis)","volume":"41","author":"Kossard","year":"2000","journal-title":"Australas J Dermatol."},{"key":"R45-20250616","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1309\/AJCPBII68IJXUXHC","article-title":"Folliculotropic T-cell lymphocytosis as a distinct form of pilotropic T-cell dyscrasia","volume":"135","author":"Magro","year":"2011","journal-title":"Am J Clin Pathol."},{"key":"R46-20250616","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/cup.12871","article-title":"Follicular lymphomatoid papulosis with follicular mucinosis: a clinicopathologic study of 3 cases with literature review and conceptual reappraisal","volume":"44","author":"Dore","year":"2017","journal-title":"J Cutan Pathol."},{"key":"R47-20250616","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-0560.2007.00722.x","article-title":"Basaloid folliculolymphoid hyperplasia: a distinctive finding in follicular mycosis fungoides","volume":"34","author":"Gerami","year":"2007","journal-title":"J Cutan Pathol."},{"key":"R48-20250616","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00000372-198000220-00015","article-title":"Follicular lymphomatoid papulosis","volume":"2","author":"Pierard","year":"1980","journal-title":"Am J Dermatopathol."},{"key":"R49-20250616","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jaad.2012.12.952","article-title":"Follicular lymphomatoid papulosis revisited: a study of 11 cases, with new histopathological findings","volume":"68","author":"Kempf","year":"2013","journal-title":"J Am Acad Dermatol."},{"key":"R50-20250616","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1600-0560.1995.tb00764.x","article-title":"Basaloid folliculolymphoid hyperplasia with alopecia as an expression of mycosis fungoides (CTCL)","volume":"22","author":"Kossard","year":"1995","journal-title":"J Cutan Pathol."},{"key":"R51-20250616","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000251260","article-title":"Uber die akut verlaufende, nekrotisierende unterart der pityriasis lichenoides: (pityriasis lichenoides et varioliformis acuta)","volume":"45","author":"Habermann","year":"1925","journal-title":"Dermatology"},{"key":"R52-20250616","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2133.1972.tb02221.x","article-title":"Pityriasis lichenoides: a reappraisal","volume":"86","author":"Marks","year":"1972","journal-title":"Br J Dermatol."},{"key":"R53-20250616","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/PAS.0000000000001093","article-title":"Pityriasis lichenoides, atypical pityriasis lichenoides and related conditions: a study of 66 cases","volume":"42","author":"Borra","year":"2018","journal-title":"Am J Surg Pathol."},{"key":"R54-20250616","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/PAS.0b013e31824f4f66","article-title":"Pityriasis lichenoides et varioliformis acuta with numerous CD30+ cells. A variant mimicking lymphomatoid papulosis and other cutaneous lymphomas, a clinicopathologic, immunohistochemical and molecular biological study of 13 cases","volume":"36","author":"Kempf","year":"2012","journal-title":"Am J Surg Pathol."},{"key":"R57-20250616","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/DAD.0b013e31818779de","article-title":"A distinct entity in the spectrum of the CD30+ cutaneous lymphoproliferative diseases: oligolesional nodules with pseudoepitheliomatous hyperplasia followed by spontaneous resolution","volume":"31","author":"Zayour","year":"2009","journal-title":"Am J Dermatopathol."},{"key":"R58-20250616","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/DAD.0000000000001587","article-title":"Pseudocarcinomatous hyperplasia, squamous cell carcinoma, and keratoacanthoma associated to lymphomas of the skin and external mucous membranes: a case report and literature review","volume":"42","author":"Jeunon","year":"2020","journal-title":"Am J Dermatopathol."},{"key":"R60-20250616","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/bjd.17834","article-title":"Cutaneous lymphomas appearing during treatment with biologics: 44 cases from the\u00a0French study group on cutaneous lymphomas and French pharmacovigilance database","volume":"181","author":"Dequidt","year":"2019","journal-title":"Br J Dermatol."},{"key":"R61-20250616","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/cup.13588","article-title":"Follicular eruption with folliculotropic lymphocytic infiltrates associated with anti\u2010tumor necrosis factor alpha therapy: report and study of 3 cases","volume":"47","author":"Avitan-Hersh","year":"2020","journal-title":"J Cutan Pathol."},{"key":"R62-20250616","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/WOX.0b013e3181d675f8","article-title":"Pathological mechanisms of skin homing T cells in atopic dermatitis","volume":"3","author":"Ferran","year":"2010","journal-title":"World Allergy Organ J."},{"key":"R63-20250616","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1398-9995.1997.tb00177.x","article-title":"In vivo relevance of CD30 in atopic dermatitis","volume":"52","author":"Caproni","year":"1997","journal-title":"Allergy"},{"key":"R64-20250616","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/archderm.140.4.449","article-title":"CD30+ cutaneous lymphoma in association with atopic eczema","volume":"140","author":"Fletcher","year":"2004","journal-title":"Arch Dermatol."},{"key":"R65-20250616","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaad.2020.03.050","article-title":"Progression of cutaneous T-cell lymphoma after dupilumab: case review of 7 patients","volume":"83","author":"Espinosa","year":"2020","journal-title":"J Am Acad Dermatol."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002546","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T18:01:16Z","timestamp":1750096876000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,27]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000002546","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,27]]}}}